IP Verse

Glp-1 Receptor Agonists And Uses Thereof - EP3555064

The patent EP3555064 was granted to Pfizer on Mar 1, 2023. The application was originally filed on Dec 1, 2017 under application number EP17817174A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3555064

PFIZER
Application Number
EP17817174A
Filing Date
Dec 1, 2017
Status
Granted And Under Opposition
Oct 21, 2022
Grant Date
Mar 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONAug 23, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS3773919
DESCRIPTIONUS4485045
DESCRIPTIONUS4544545
DESCRIPTIONUS5013556
DESCRIPTIONWO2010022055
INTERNATIONAL-SEARCH-REPORTUS2004127504
INTERNATIONAL-SEARCH-REPORTWO2011143365
OPPOSITIONUS2003162790
OPPOSITIONUS2004127504
OPPOSITIONUS2008280933
OPPOSITIONUS2012028959
OPPOSITIONUS5714498
OPPOSITIONUS5780475
OPPOSITIONWO2011143365

Non-Patent Literature (NPL) Citations (29) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- B. C. FINNIN; T. M. MORGAN, J. Pharm. Sci., (19990000), vol. 88, pages 955 - 958-
DESCRIPTION- CHOI, J. Y. et al., J. Med. Chem., (20120000), vol. 55, pages 852 - 870-
DESCRIPTION- Compendium of Organic Synthetic Methods, Wiley-Interscience, vol. I-XII-
DESCRIPTION- Comprehensive Organic Chemistry, Elsevier-
DESCRIPTION- Current Opinion in Drug Discovery and Development, (20070000), vol. 10, page 550-
DESCRIPTION- "Designing Prodrugs and Bioprecursors", Y. M. CHOI-SLEDESKI; C. G. WERMUTH, Practice of Medicinal Chemistry, Elsevier, (20150000), pages 657 - 696-
DESCRIPTION- HALEBLIAN, J Pharm Sci, (19750800), vol. 64, no. 8, pages 1269 - 1288-
DESCRIPTION- HAMPP, C. et al., "Use of Antidiabetic Drugs in the U.S., 2003-2012", Diabetes Care, (20140000), vol. 37, pages 1367 - 1374-
DESCRIPTION- HOIST, Physiol. Rev., (20070000), vol. 87, page 1409-
DESCRIPTION- LAROCK, Comprehensive Organic Transformations: A Guide to Functional Group Preparations, John Wiley and Sons-
DESCRIPTION- LUNDGREN; STRADIOTTO, Aldrich Chimica Acta, (20120000), vol. 45, pages 59 - 65-
DESCRIPTION- MALUENDA; NAVARRO, Molecules, (20150000), vol. 20, pages 7528 - 7557-
DESCRIPTION- MEIER et al., Biodrugs, (20030000), vol. 17, no. 2, pages 93 - 102-
DESCRIPTION- MEIER, Nat. Rev. Endocrinol., (20120000), vol. 8, page 728-
DESCRIPTION- Nature Reviews/Drug Discovery, (20080000), vol. 7, page 355-
DESCRIPTION- O. ALMARSSON; M. J. ZAWOROTKO, Chem Commun, (20040000), vol. 17, pages 1889 - 1896-
DESCRIPTION- "Supercritical Fluid Chromatography with Packed Columns", SMITH, ROGER M., Chromatographic Science Series, Loughborough University, (19980000), vol. 75, pages 223 - 249-
DESCRIPTION- SWAMY et al., Chem. Rev., (20090000), vol. 109, pages 2551 - 2651-
DESCRIPTION- T. HIGUCHI; W. STELLA, "Pro-drugs as Novel Delivery Systems", ACS Symposium Series, vol. 14-
DESCRIPTION- VILSBOLL T et al., Diabetes, (20010000), vol. 50, pages 609 - 613-
OPPOSITION- Stevens Efland, "Chapter 10 Lead Discovery", Stevens Efland, Stevens Efland, Medicinal Chemistry: The Modern Drug Discovery Process, Pearson, (20130101), pages 247 - 272, ISBN 978-0-321-89270-6, XP093229891-
OPPOSITION- Zaragoza Dörwald, Florencio, "Chapter 1: Organic Synthesis: General Remarks", Zaragoza Dörwald, Florencio, Florencio Zaragoza Dörwald, Side Reactions in Organic Synthesis - A Guide to Successful Synthesis Design, DE, Wiley- VCH, (20041227), pages 1 - 16, ISBN 3-527-31021-5, XP009555519-
OPPOSITION- Simon J. Teague, Andrew M. Davis, Paul D. Leeson, Tudor Oprea, "The design of leadlike combinatorial libraries", Angewandte Chemie International Edition, Hoboken, USA, (19990101), vol. 38, no. 24, doi:10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U, ISSN 1433-7851, pages 3743 - 3748, XP002511933
OPPOSITION- Chen Lili, Yun Ying, Guo Shimeng, Wang Xiaoyan, Xiong Muya, Zhao Tingting, Xu Tifei, Shen Jianhua, Xie Xin, Wang Kai, "Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists", Journal of Medicinal Chemistry, US , (20230622), vol. 66, no. 12, doi:10.1021/acs.jmedchem.3c00320, ISSN 0022-2623, pages 7988 - 8010, XP093229883
OPPOSITION- Horner Kate E., Karadakov Peter B., "Shielding in and around Oxazole, Imidazole, and Thiazole: How Does the Second Heteroatom Affect Aromaticity and Bonding?", The Journal of Organic Chemistry, American Chemical Society, United States, United States, (20150717), vol. 80, no. 14, doi:10.1021/acs.joc.5b01010, ISSN 0022-3263, pages 7150 - 7157, XP093183308
OPPOSITION- Vassil I. Ognyanov, Chenera Balan, Anthony W. Bannon, Yunxin Bo, Celia Dominguez, Christopher Fotsch, Vijay K. Gore, Lana Klionsky, Vu V. Ma, Yi-Xin Qian, Rami Tamir, Xianghong Wang, Ning Xi, Shimin Xu, Dawn Zhu, Narender R. Gavva, James J. S. Treanor, and Mark H. Norman, "Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure-Activity Relationships of 2-Piperazin-1-yl-1·H- benzimidazoles", Journal of Medicinal Chemistry, American Chemical Society, US, US , (20060519), doi:10.1021/jm060065y, ISSN 0022-2623, XP008140456
OPPOSITION- Beker Wiktor, Szarek Paweł, Komorowski Ludwik, Lipiński Józef, "Reactivity Patterns of Imidazole, Oxazole, and Thiazole As Reflected by the Polarization Justified Fukui Functions", The Journal of Physical Chemistry A, Washington DC, US, US , (20130221), vol. 117, no. 7, doi:10.1021/jp309390j, ISSN 1089-5639, pages 1596 - 1600, XP093183306
OPPOSITION- Kaspady Mohamed, Narayanaswamy Venugopala, Raju Mohana, Rao Gopal, "Synthesis, Antibacterial Activity of 2,4-Disubstituted Oxazoles and Thiazoles as Bioisosteres", LETTERS IN DRUG DESIGN AND DISCOVERY, BENTHAM SCIENCE PUBLISHERS, US, US , (20090101), vol. 6, no. 1, doi:10.2174/157018009787158481, ISSN 1570-1808, pages 21 - 28, XP093183309
OPPOSITION- Sloop Kyle W., Willard Francis S., Brenner Martin B., Ficorilli James, Valasek Kathleen, Showalter Aaron D., Farb Thomas B., Cao Julia X.C., Cox Amy L., Michael M. Dodson, Gutierrez Sanfeliciano Sonia Maria, Tebbe Mark J., Coghlan Michael J., "Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets", Diabetes, (20101201), vol. 59, no. 12, doi:10.2337/db10-0689, ISSN 0012-1797, pages 3099 - 3107, XP093229902

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents